Orient Europharma Financials
| 4120 Stock | TWD 48.10 0.30 0.63% |
Orient |
Understanding current and past Orient Europharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Orient Europharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Orient Europharma's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Orient Europharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Orient Europharma Co. Check Orient Europharma's Beneish M Score to see the likelihood of Orient Europharma's management manipulating its earnings.
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0004120001 |
| Business Address | No 368, Fu |
| Sector | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.oepgroup.com |
| Phone | 886 2 2755 4881 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Orient Europharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Orient Stock, because this is throwing your money away. Analyzing the key information contained in Orient Europharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Orient Europharma Key Financial Ratios
There are many critical financial ratios that Orient Europharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Orient Europharma reports annually and quarterly.| Return On Equity | -0.0268 | |||
| Return On Asset | -0.0027 | |||
| Number Of Employees | 21 | |||
| Beta | 0.4 | |||
| Z Score | 0.6 |
Orient Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Orient Europharma's current stock value. Our valuation model uses many indicators to compare Orient Europharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orient Europharma competition to find correlations between indicators driving Orient Europharma's intrinsic value. More Info.Orient Europharma Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orient Europharma's earnings, one of the primary drivers of an investment's value.Orient Europharma Systematic Risk
Orient Europharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Orient Europharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Orient Europharma correlated with the market. If Beta is less than 0 Orient Europharma generally moves in the opposite direction as compared to the market. If Orient Europharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Orient Europharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Orient Europharma is generally in the same direction as the market. If Beta > 1 Orient Europharma moves generally in the same direction as, but more than the movement of the benchmark.
Orient Europharma January 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Orient Europharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Orient Europharma Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Orient Europharma Co based on widely used predictive technical indicators. In general, we focus on analyzing Orient Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Orient Europharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 18.14 | |||
| Value At Risk | (1.81) | |||
| Potential Upside | 1.91 |
Additional Tools for Orient Stock Analysis
When running Orient Europharma's price analysis, check to measure Orient Europharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Europharma is operating at the current time. Most of Orient Europharma's value examination focuses on studying past and present price action to predict the probability of Orient Europharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Europharma's price. Additionally, you may evaluate how the addition of Orient Europharma to your portfolios can decrease your overall portfolio volatility.